RiverVest Venture Partners® focuses exclusively on innovations in life sciences, a field in which our team has significant research, clinical, operational and investment expertise.
Our team’s deep domain experience allows us to identify, found and actively incubate promising life science companies, particularly in the medical device and biopharmaceutical industries. We provide practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward.
RiverVest also invests in select later-stage life science companies to diversify risk and maximize portfolio returns. In every case, we take a hands-on investment approach, preferring to be represented on the boards of our portfolio companies.
Established in 2000, RiverVest has funded 29 innovative life science companies and currently has assets under management of $208 million.
• Established in 2000
• $250 million assets under management
• 29 life science companies funded
• Six companies founded leading to three acquisitions
• 15 exits